Loading the player ...
Comments | Policy
Science Talk: Einstein Receives High-Risk/High-Reward Cancer Research Funding
December 7, 2009 — Matthew Levy, Ph.D., assistant professor of biochemistry at Albert Einstein College of Medicine of Yeshiva University, has been awarded more than $700,000 by Stand Up To Cancer (SU2C) for his high-risk/high-reward cancer research. Dr. Levy's work will focus on creating self-guiding drugs that target only cancer cells, thus eliminating or significantly reducing serious or unpleasant side effects of current therapies. See accompanying release (December 07, 2009)
- Subscribe:
